We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.04B
Cap. Flow %
8.47%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,117
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HGV icon
3176
Hilton Grand Vacations
HGV
$3.31B
-82,934
Closed -$3.43M
HI
3177
DELISTED
Hillenbrand
HI
-64,432
Closed -$2.84M
HIG icon
3178
Hartford Financial Services
HIG
$38.7B
-26,424
Closed -$1.64M
HL icon
3179
Hecla Mining
HL
$11.8B
-568,673
Closed -$4.23M
HLT icon
3180
Hilton Worldwide
HLT
$70B
-25,551
Closed -$3.08M
HLX icon
3181
Helix Energy Solutions
HLX
$1.47B
-66,027
Closed -$377K
HOLX
3182
DELISTED
Hologic
HOLX
-29,187
Closed -$1.95M
HON icon
3183
Honeywell
HON
$77B
-19,449
Closed -$4.02M
HTGC icon
3184
Hercules Capital
HTGC
$3.21B
-11,766
Closed -$201K
HTLD icon
3185
Heartland Express
HTLD
$911M
-12,636
Closed -$216K
HUBG icon
3186
HUB Group
HUBG
$2.9B
-70,846
Closed -$2.34M
HUM icon
3187
Humana
HUM
$46.3B
-5,222
Closed -$2.31M
HUMAW icon
3188
CALL
Humacyte Inc Warrant
HUMAW
$1.38M
-108,979
Closed -$1.11M
IART icon
3189
Integra LifeSciences
IART
$1.33B
-28,856
Closed -$1.97M
IBB icon
3190
iShares Biotechnology ETF
IBB
$9.82B
-796
Closed -$134K
IBIO icon
3191
iBio
IBIO
$69.5M
-341
Closed -$257K
IDCC icon
3192
InterDigital
IDCC
$8.99B
-17,595
Closed -$1.28M
IEF icon
3193
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
-2,300
Closed -$266K
IEF icon
3194
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
-14,492
Closed -$1.69M
IGV icon
3195
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$15.1B
-462,500
Closed -$36.1M
IH
3196
iHuman
IH
$67M
-19,660
Closed -$203K
IMMP
3197
Immutep
IMMP
$56.6M
-165,768
Closed -$642K
IMO icon
3198
Imperial Oil
IMO
$62.3B
-121,918
Closed -$3.72M
INDA icon
3199
iShares MSCI India ETF
INDA
$6.6B
-29,600
Closed -$1.31M
INGN icon
3200
Inogen
INGN
$163M
-12,473
Closed -$813K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.04B of net new capital in Q3 2021, opening 1,117 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,117 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.